Hong Sun, MD, PhD


Raising Awareness for Rare Diseases, Myasthenia Gravis: Hong Sun, MD, PhD

The global compound development team leader at Janssen discussed the importance of Rare Disease Day and one in particular, myasthenia gravis, which affects approximately 36,000 to 60,000 people in the US. [WATCH TIME: 3 minutes]

Dalia Rotstein, MD, MPH


Beginning and Transitioning DMT in MS: Dalia Rotstein, MD, MPH

The assistant professor of medicine at University of Toronto, and neurologist at St. Michael's Hospital spoke about the process of changing or beginning treatment with a variety of disease-modifying therapies in multiple sclerosis. [WATCH TIME: 4 minutes]

Ada Metaxas, BSE-C


The Impact of a Social Media–Based Educational Intervention to Promote Training in Social Determinants of Health Among Medical Residents

Social determinants of health are conditions that people are born into and live under that affect their health, and can greatly impact clinical outcomes as well as contribute to health disparities and inequalities.

Shae Datta, MD


Newly Approved Migraine Nasal Spray Offers Alternative Treatment to Injections, Oral Medications: Shae Datta, MD

The neurologist and migraine expert from NYU Langone Health shared her reactions to the recently approved zavegepant nasal spray (Zavzpret; Pfizer) for the treatment of migraine. [WATCH TIME: 5 minutes]

Ruth Benca, MD, PhD


Assessing the Correlations With Sleep Issues and Risk of Dementia: Ruth Benca, MD, PhD

The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine provided insight on the signs and risks associated with sleep disorders and Alzheimer disease. [WATCH TIME: 3 minutes]

Susan Matulevicius, MD, MSCS


AUPN Leadership Minute Episode 19: Happy Faculty-Happy Life: Improving Faculty Satisfaction

Episode 19 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University; and Susan Matulevicius, MD, MSCS, of UT Southwestern Medical Center. [WATCH TIME: 4 minutes]

Stewart Factor, DO


The Therapeutic Pipeline for Parkinson Disease: Stewart Factor, DO

The director of the Parkinson’s Disease and Movement Disorder Program at Emory University School of Medicine shared his perspective on the research and development of Parkinson therapies.

Bruce Hughes, MD


Access to Biomarkers in MS

Bruce Hughes, MD, comments on the current use and access to biomarkers in MS management, as well as sharing how NfL is being used in clinical practice presently.

Nicholas Varvel


Broad Anti-inflammatory Approaches Feasible for Epilepsy: Nicholas Varvel, PhD

The assistant professor in the department of pharmacology and chemical biology at Emory University School of Medicine spoke about immune cells in epilepsy based on his special lecture at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]

Colin Josephson, MD, MSc, FRCPC


Clinician and Patient Collaboration Advances Research and Epilepsy Care: Colin Josephson, MD, MSc, FRCPC

The associate professor of neurology at the University of Calgary spoke about advancing epilepsy care through patient-oriented research at the 2022 AES Annual Meeting. [WATCH TIME: 6 minutes]

Rebecca Whitney


An Inside Look at the 2022 RNDS, SRNA's Hybrid Conference

The RNDS, created to bring together those with rare neuroimmune disorders and clinical community together, is a 3-day hybrid educational event held October 7-9 in Los Angeles, California

Mill Etienne, MD


AUPN Leadership Minute Episode 25: Patching the Holes in the Pipeline: Strategies to Enhance Diversity, Equity and Inclusion in Neurology

Episode 25 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Mill Etienne, MD, of New York Medical College. [WATCH TIME: 8 minutes]

Courtney Young, PhD


Revolutionizing Treatment For Duchenne Muscular Dystrophy with Gene Editing: Courtney Young, PhD

The co-founder and chief executive officer of MyoGene Bio talked about the advantages of gene editing over traditional gene therapy as a long term treatment for neuromuscular diseases at MDA’s 2023 conference. [WATCH TIME: 3 minutes]

Melanie Quintana, PhD


The Implementation of Platform Trials for ALS Research: Melanie Quintana, PhD

The senior statistical scientist and director of consulting at Berry Consultants talked about innovative clinical trial design in ALS research at the 2023 MDA conference. [WATCH TIME: 5 minutes]

Aparna V.R. Polavarapu, MD


Aparna V.R. Polavarapu, MD: Early Treatment for Infantile Spasms

The pediatric neurologist at Montefiore Health System explains the importance of treating infantile spasms as early as possible and how it may impact outcomes.

Rachel Alvarez


Mission Behind Cure CMD’s Research Roundtable, Efforts Around CMDs: Rachel Alvarez

The executive director of Cure CMD discussed efforts being done to bring the stakeholder community together and improve the care for patients with congenital muscular dystrophies. [WATCH TIME: 4 minutes]

Patricia Melville, RN, MSN, NP-C, MSCN


Concluding Thoughts on Biosimilars in Multiple Sclerosis

Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.

Steven Arnold, MD


Steven Arnold, MD: Assessing AMX0035 Efficacy in Alzheimer Disease

The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the process of determining the best situations for use of AMX0035.

Alan Towne, MD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Christal Mickle


Expanding KP1077’s Clinical Program to Address Narcolepsy and Other Conditions: Christal Mickle

The cofounder and chief product development officer of Zevra Therapeutics talked about the phase 1 clinical trial of KP1077 for narcolepsy and potentially using it to treat other conditions. [WATCH TIME: 5 minutes]

Jodi A. Mindell, PhD


Differences in Approaches to Pediatric and Adult Sleep Disorders: Jodi A. Mindell, PhD

The associate director of the Sleep Center at Children’s Hospital of Philadelphia detailed the similarities and differences in how sleep disorders are viewed between children and adults. [WATCH TIME: 4 minutes]

Ian Kremer
Ian Kremer


Public, Private Sector Collaboration Essential to Aducanumab's Success in Alzheimer Disease: Ian Kremer, LEAD Coalition

The executive director of the LEAD Coalition calls for greater collaboration and support from government and the healthcare community in order to boost health equity.

Robert W. Motl, PhD


Exercise Training and Multiple Sclerosis

In line with the push for more comprehensive care, literature suggests that patients with multiple sclerosis benefit from physical therapy interventions to help manage disease symptoms.

Jason Freeman, MD, MBA


Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis

Jason Freeman, MD, MBA, and Brandon Brown, PharmD, discuss the poster “Five-Year Safety of Ofatumumab in People Living with Relapsing Multiple Sclerosis” presented at AAN 2023. Sponsored By Novartis.

Lauren Treat, MD


Standardizing Clinical Practice for End of Life Care in Neuromuscular Diseases: Lauren Treat, MD

The child neurologist at the University of Colorado School of Medicine talked about her presentation on end of life care for patients with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]

Julio R. Vieira, MD


Future Directions for the Management of Migraine

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.

Mary Ann Picone, MD


Advice for Physicians and the Multiple Sclerosis Community

The panel shares final advice for the multiple sclerosis community.

Ulrik Dalgas, PhD


Intervening Early in MS With Exercise: Ulrik Dalgas, PhD

The professor of public health and sports science at Aarhus University shared his perspective on the potential to modify multiple sclerosis disease progression with lifestyle interventions. [WATCH TIME: 2 minutes]

© 2023 MJH Life Sciences

All rights reserved.